The number of new cases of emerging fungal infections has increased considerably in recent years, mainly due to the large number of immunocompromised individuals. The objective of this study was to evaluate the susceptibility of emerging fungi to fluconazole, itraconazole and amphotericin B by disk diffusion method. In 2015, 82 emerging fungi were evaluated in IPB-LACEN/RS and 13 (15.8%) were resistant: 10/52 were from superficial mycoses and 3/30 from systemic mycoses. The data from the study point to the need for permanent vigilance regarding the careful evaluation in the prescription and clinical and laboratory follow-up of patients affected by fungal infections. Keywords: Antifungal agents; Drug resistance; Mycology Fungal resistance has been increasing in many areas throughout the world and determining the sensitivity profile of the agents allows for a safe practice. Among the many methods available to evaluate the sensitivity, the disk diffusion method (DD) is affordable and easily reproducible. to the gender and HIV infection status. There were no significant differences (using the chi-square test and considering p < 0.05) between these relationships. Fluconazole was the antifungal to which the largest number of strains was resistant (9/82). The resistance
affordable and easily reproducible. 1, 2 We conducted a study to eval- We demonstrated in this study that the susceptibility to the antifungals tested was not influenced by the site of the lesion nor by HIV infection, but by age -the resistant cases were in older individuals. The larger number of cases of superficial mycoses occurred in women, suggesting a higher exposure and seeking of medical assistance. C. albicans continues to be one of the main causes for invasive infections but, the incidence of C. parapsilosis has grown significantly. 5 Resistance to amphotericin B was the lowest among the drugs tested and was actually related to a little cited species in the literature, Candida famata. 6 Studies with C. albicans samples from patients with recurrent infections showed that the resistance to fluconazole occurred in the same infections where the previous species were susceptible. This confirms data from other studies in which the strains changed over the course of exposure to the patient, characterizing acquired resistance. 
